British Business Bank invests £21m to support medical technology
The British Business Bank (BBB) has announced a significant new investment to support the growth of the medical technology sector. The state-owned bank has committed £21.26 million to the Health Economics 3 Fund, which is managed by EQT Life Sciences.
This fund focuses on providing financial support to companies that are developing new healthcare solutions. By investing in these businesses, the fund aims to encourage innovation in medical treatments and health technology. The partnership is designed to help promising companies grow and bring their products to the market more quickly.
Medical technology is an important area for the UK economy, as it combines scientific research with business development. The British Business Bank plays a key role in supporting such industries by providing capital that might otherwise be difficult for smaller firms to access.
This investment is part of a wider effort to strengthen the UK's position as a global leader in life sciences. By backing specialized funds like EQT HE3, the government-backed bank hopes to create more jobs and improve patient care through modern technology.
Looking ahead, this funding is expected to provide a boost to the development of new medical devices and digital health tools. The British Business Bank continues to focus on supporting long-term economic growth across various sectors in the United Kingdom.